Literature DB >> 19564573

TLR4-mediated Cox-2 expression increases intestinal ischemia/reperfusion-induced damage.

Tiffany Moses1, Lynn Wagner, Sherry D Fleming.   

Abstract

Mesenteric IR induces significant inflammation and immune-mediated mucosal damage. TLR4 is a critical receptor in the induction of the inflammatory response and plays a role in intestinal homeostasis. To determine the role of TLR4 in IR-induced epithelial damage, we performed IR studies using TLR4(lps-def) and TLR4(lps-n) mice and analyzed mucosal damage and inflammation. We found that the absence of TLR4 or TLR4-induced signaling attenuated local mucosal damage with significantly decreased cytokine and eicosanoid secretion including PGE2 production. Similar results were seen in MyD88-/- mice. Wild-type mice treated with NS-398 (a Cox-2 inhibitor) not only decreased PGE2 production but also attenuated tissue damage. In contrast, PGE2 was not sufficient to induce damage in the TLR4(lps-def) mice. Together, these data indicate that TLR4 stimulation of Cox-2 activation of PGE2 production is necessary but not sufficient for intestinal IR-induced damage and inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19564573      PMCID: PMC2752016          DOI: 10.1189/jlb.0708396

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  41 in total

Review 1.  Innate immunity: an overview.

Authors:  Bruce Beutler
Journal:  Mol Immunol       Date:  2004-02       Impact factor: 4.407

Review 2.  Endogenous ligands of Toll-like receptors.

Authors:  Min-Fu Tsan; Baochong Gao
Journal:  J Leukoc Biol       Date:  2004-06-03       Impact factor: 4.962

3.  Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis.

Authors:  Seth Rakoff-Nahoum; Justin Paglino; Fatima Eslami-Varzaneh; Stephen Edberg; Ruslan Medzhitov
Journal:  Cell       Date:  2004-07-23       Impact factor: 41.582

4.  Accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice.

Authors:  Sherry D Fleming; Marc Monestier; George C Tsokos
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

5.  Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal.

Authors:  C J Chiu; A H McArdle; R Brown; H J Scott; F N Gurd
Journal:  Arch Surg       Date:  1970-10

6.  Induction of heat-shock protein 72 protects against ischemia/reperfusion in rat small intestine.

Authors:  A Stojadinovic; J Kiang; R Smallridge; R Galloway; T Shea-Donohue
Journal:  Gastroenterology       Date:  1995-08       Impact factor: 22.682

7.  Toll-like receptor 4 involvement in hepatic ischemia/reperfusion injury in mice.

Authors:  He-Shui Wu; Jin-Xiang Zhang; Lin Wang; Yuan Tian; Hui Wang; Ori Rotstein
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2004-05

8.  Comparative protection against rat intestinal reperfusion injury by a new inhibitor of sPLA2, COX-1 and COX-2 selective inhibitors, and an LTC4 receptor antagonist.

Authors:  Thiruma V Arumugam; Naomi Arnold; Lavinia M Proctor; Michelle Newman; Robert C Reid; Karl A Hansford; David P Fairlie; Ian A Shiels; Stephen M Taylor
Journal:  Br J Pharmacol       Date:  2003-07-29       Impact factor: 8.739

9.  Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart.

Authors:  Albert J Chong; Akira Shimamoto; Craig R Hampton; Hiroo Takayama; Denise J Spring; Christine L Rothnie; Masaki Yada; Timothy H Pohlman; Edward D Verrier
Journal:  J Thorac Cardiovasc Surg       Date:  2004-08       Impact factor: 5.209

Review 10.  TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression.

Authors:  Stefanie N Vogel; Katherine A Fitzgerald; Matthew J Fenton
Journal:  Mol Interv       Date:  2003-12
View more
  32 in total

Review 1.  Intestinal ischemia/reperfusion: microcirculatory pathology and functional consequences.

Authors:  Brigitte Vollmar; Michael D Menger
Journal:  Langenbecks Arch Surg       Date:  2010-11-19       Impact factor: 3.445

2.  Helicobacter infection alters MyD88 and Trif signalling in response to intestinal ischaemia-reperfusion.

Authors:  Sara M Hoffman; Hua Wang; Michael R Pope; Sherry D Fleming
Journal:  Exp Physiol       Date:  2010-11-05       Impact factor: 2.969

3.  Pathophysiology of motility dysfunction in bowel obstruction: role of stretch-induced COX-2.

Authors:  Xuan-Zheng Shi; You-Min Lin; Don W Powell; Sushil K Sarna
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-11-04       Impact factor: 4.052

4.  DNA attenuates enterocyte Toll-like receptor 4-mediated intestinal mucosal injury after remote trauma.

Authors:  Chhinder Sodhi; Ryan Levy; Roop Gill; Matthew D Neal; Ward Richardson; Maria Branca; Anthony Russo; Thomas Prindle; Timothy R Billiar; David J Hackam
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-01-13       Impact factor: 4.052

5.  Small β2-glycoprotein I peptides protect from intestinal ischemia reperfusion injury.

Authors:  Michael R Pope; Urska Bukovnik; John M Tomich; Sherry D Fleming
Journal:  J Immunol       Date:  2012-10-03       Impact factor: 5.422

Review 6.  Membrane lipid interactions in intestinal ischemia/reperfusion-induced Injury.

Authors:  Emily Archer Slone; Sherry D Fleming
Journal:  Clin Immunol       Date:  2014-05-09       Impact factor: 3.969

7.  Intestinal lipid alterations occur prior to antibody-induced prostaglandin E2 production in a mouse model of ischemia/reperfusion.

Authors:  Byron L Sparkes; Emily E Archer Slone; Mary Roth; Ruth Welti; Sherry D Fleming
Journal:  Biochim Biophys Acta       Date:  2010-01-18

8.  Cyclooxygenase 2, toll-like receptor 4 and interleukin 1β mRNA expression in atherosclerotic plaques of type 2 diabetic patients.

Authors:  Alessandro Baldan; Silvia Ferronato; Silvia Olivato; Giovanni Malerba; Alberto Scuro; Gian Franco Veraldi; Matteo Gelati; Sergio Ferrari; Sara Mariotto; Pier Franco Pignatti; Sara Mazzucco; Macarena Gomez-Lira
Journal:  Inflamm Res       Date:  2014-08-06       Impact factor: 4.575

9.  TLR9 is dispensable for intestinal ischemia/reperfusion-induced tissue damage.

Authors:  Emily Archer Slone; Michael R Pope; Mary Roth; Ruth Welti; Sherry D Fleming
Journal:  Am J Clin Exp Immunol       Date:  2012

Review 10.  Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to Bedside.

Authors:  Avijit Dey; Xu Kang; Jiange Qiu; Yifeng Du; Jianxiong Jiang
Journal:  Trends Pharmacol Sci       Date:  2016-04-06       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.